The Bottom Line The FTC made it clear many times in 2018 that disease efficacy claims must be supported by competent and reliable scientific evidence, including human clinical testing, and that expert opinions will help guide the kind of human clinical testing and the number of RCTs that is Continue Reading
ANA Advertising Law & Public Policy Conference
Davis+Gilbert is a proud sponsor of the 2018 Association of National Advertisers Advertising Law & Public Policy Conference to be held in Washington, D.C. on March 15-16. Ronald R. Urbach, Chairman of Davis+Gilbert and Co-Chair of the firm’s Advertising + Marketing Practice Group, will speak Continue Reading